Compared to compromised PDC activity, the full rescue of impaired prostate tumor cell proliferation requires expression of both MTS-KMT9α and NLS-KMT9α, which is in accordance with our previous characterization of KMT9 functions in the nucleus17. The gene discussed is HEMK2; the disease is prostate neoplasm.